NCT04349722

The Effect of Hyoscine-N-butylbromide (HBB, Buscopan) in Augmented Labour Among Primigravidae

A Randomised Control Study: The Effect of Hyoscine-N-butylbromide (HBB, Buscopan) in Augmented Labour Among Primigravidae

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 110 (actual)
• Sponsor: National University of Malaysia · Academic / Other
• Sex: Female
• Age: 18 Years
• Healthy volunteers: Accepted

Summary

This study compares the duration of active phase of labour in women who received buscopan and those who don't.

Detailed description

A randomised control study involving primigravida in labour who require pitocin augmentation. Once patient require augmentation, patient will be randomised into intervention group (receiving intravenous buscopan 1ml or 20mg) and control group (intravenous normal saline 1ml). Both fluids are colourless. The primary outcome is duration from augmentation to os fully. The secondary outcome are to look on mode of delivery particularly any caesarean section due to failure to poor progress, maternal side effect (dry mouth and tachycardia) and baby outcome (apgar score and neonatal intensive care unit admission)

Conditions

• Labor Long

Interventions

Type	Name	Description
DRUG	Hyoscine Butylbromide	Intervention is given once a participant is in established labor
OTHER	Placebo	Intervention is given once a participant is in established labor

Timeline

• Start date: 2019-12-01
• Primary completion: 2020-06-30
• Completion: 2020-06-30
• First posted: 2020-04-16
• Last updated: 2022-04-06

Locations

1 site across 1 country: Malaysia